-
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the U.S. and will have a list price of $1,400. But its impact will hinge on how easily people can access it, experts say. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSSPolicy & Advocacy
-
The federal government is restricting COVID-19 vaccine access. Here’s what that means for the ongoing pandemic and people with Long COVID.
-
Long COVID is increasing housing insecurity, but support programs fail to help
-
Minnesota’s unique Long COVID program retains funding following advocacy
-
Los Angeles’ $13M COVID-19 relief funds could go to building upgrades, not Long COVID care
-
Illinois could become the first state in the country to ban mask bans. Here’s how we created the bill to do it.
-
Secretary Kennedy promises to support Long COVID treatment research in Senate hearing, says son is “dramatically affected”
Science
-
Long COVID affects millions of children. The largest pediatric trial so far launches this year.
-
Research updates, February 3
-
Research updates, January 27
-
New RECOVER-TLC trials won’t enroll until summer. Nearly two years after the program’s launch.
-
Research updates, January 20
-
Severe people may hold answers to Long COVID. They must be included in research.
Covid-19
Health
-
Alice Wong, disability activist and luminary, dies at 51
-
As the American West faces increasing air pollution, protecting the right to mask is vital
-
Business school competition centers Long COVID and IACCs
-
Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?
-
NBA player Kristaps Porziņģis shares POTS diagnosis
-
Shutdown leaves gaps in states’ health data, possibly endangering lives
-
The U.K.’s plan for ME has failed us. Members of parliament must step up.
-
Work until you disappear: Long COVID ensnared me in an exploitative health system
-
We must free Long COVID and the people living with it from the mind-body trap
-
Research ethics boards need urgent training on Long COVID and myalgic encephalomyelitis